FDA Inspection 978304 — Vitalant

Vitalant — FEI 2275064

The FDA completed an inspection of Vitalant on July 19, 2016 in Montvale, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Montvale, NJ (United States)